Among Covid-19 vaccine technologies, mRNA represents faster, easier approach, some experts say

There are multiple platforms for developing vaccines against the SARS-CoV-2 virus, including messenger RNA, DNA and molecular clamp. Moderna said last week that it had dosed the first patient in its Phase I mRNA vaccine trial.